Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT06958094
Eligibility Criteria:
* Inclusion Criteria:
* Population with cystic fibrosis (CF), aged 8-20 years.
* Individuals using or not using CFTR modulators (e.g., Kaftrio, Kalydeco, etc.), regardless of their specific mutation.
* Exclusion Criteria:
* Forced Vital Capacity (FVC) and/or Forced Expiratory Volume in the first second (FEV1) \< 40%.
* Oxygen therapy or continuous mechanical ventilation.
* Moderate hemoptysis or recent pneumothorax (within the past 3 months).
* Presence of an active, uncontrolled respiratory infection exacerbation that required hospitalization within the 30 days prior to the intervention.
* Other conditions such as neuromuscular disorders or cognitive difficulties (Mini-Mental State Examination score \< 19 points).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
20 Years
Study:
NCT06958094
Study Brief:
Protocol Section:
NCT06958094